Supplementary Table 1 from Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas

Supplementary Table 1 from Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas

<p>Drug Screening Data</p>

Sábháilte in:

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Gerhard Jungwirth (15047922) (author)
Rannpháirtithe:	Tao Yu (15047925) (author), Fang Liu (15047928) (author), Junguo Cao (15047931) (author), Montadar Alaa Eddine (15047934) (author), Mahmoud Moustafa (15047937) (author), Amir Abdollahi (15026702) (author), Rolf Warta (15047940) (author), Andreas Unterberg (15047943) (author), Christel Herold-Mende (15047946) (author)
Foilsithe / Cruthaithe:	2025
Ábhair:	Cancer Therapeutic Research and Development CNS Cancers Small Molecule Agents Translational Research
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Bí ar an gcéad duine le trácht a dhéanamh!

Cannot write session to /tmp/vufind_sessions/sess_5eacuen0d8i77o6id27vvdgmmd